Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

852 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Exploratory research for optimal GvHD prophylaxis after single unit CBT in adults: short-term methotrexate reduced the incidence of severe GvHD more than mycophenolate mofetil.
Terakura S, Wake A, Inamoto Y, Murata M, Sakai R, Yamaguchi T, Takahashi S, Uchida N, Onishi Y, Ohashi K, Ozawa Y, Kanamori H, Yamaguchi H, Fukuda T, Ichinohe T, Takanashi M, Atsuta Y, Teshima T. Terakura S, et al. Among authors: kanamori h. Bone Marrow Transplant. 2017 Mar;52(3):423-430. doi: 10.1038/bmt.2016.255. Epub 2016 Dec 12. Bone Marrow Transplant. 2017. PMID: 27941766
Impact of conditioning intensity and TBI on acute GVHD after hematopoietic cell transplantation.
Nakasone H, Fukuda T, Kanda J, Mori T, Yano S, Kobayashi T, Miyamura K, Eto T, Kanamori H, Iwato K, Uchida N, Mori S, Nagamura-Inoue T, Ichinohe T, Atsuta Y, Teshima T, Murata M; GVHD working group of the Japan Society of Hematopoietic Cell Transplantation. Nakasone H, et al. Among authors: kanamori h. Bone Marrow Transplant. 2015 Apr;50(4):559-65. doi: 10.1038/bmt.2014.293. Epub 2014 Dec 22. Bone Marrow Transplant. 2015. PMID: 25531281 Clinical Trial.
Patient-reported quality of life after allogeneic hematopoietic cell transplantation or chemotherapy for acute leukemia.
Kurosawa S, Yamaguchi T, Mori T, Kanamori H, Onishi Y, Emi N, Fujisawa S, Kohno A, Nakaseko C, Saito B, Kondo T, Hino M, Nawa Y, Kato S, Hashimoto A, Fukuda T. Kurosawa S, et al. Among authors: kanamori h. Bone Marrow Transplant. 2015 Sep;50(9):1241-9. doi: 10.1038/bmt.2015.137. Epub 2015 Jun 15. Bone Marrow Transplant. 2015. PMID: 26076127 Clinical Trial.
Impact of MRD and TKI on allogeneic hematopoietic cell transplantation for Ph+ALL: a study from the adult ALL WG of the JSHCT.
Nishiwaki S, Imai K, Mizuta S, Kanamori H, Ohashi K, Fukuda T, Onishi Y, Takahashi S, Uchida N, Eto T, Nakamae H, Yujiri T, Mori S, Nagamura-Inoue T, Suzuki R, Atsuta Y, Tanaka J. Nishiwaki S, et al. Among authors: kanamori h. Bone Marrow Transplant. 2016 Jan;51(1):43-50. doi: 10.1038/bmt.2015.217. Epub 2015 Sep 21. Bone Marrow Transplant. 2016. PMID: 26389833 Clinical Trial.
Sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: Incidence, risk factors and outcomes.
Yakushijin K, Atsuta Y, Doki N, Yokota A, Kanamori H, Miyamoto T, Ohwada C, Miyamura K, Nawa Y, Kurokawa M, Mizuno I, Mori T, Onizuka M, Taguchi J, Ichinohe T, Yabe H, Morishima Y, Kato K, Suzuki R, Fukuda T. Yakushijin K, et al. Among authors: kanamori h. Bone Marrow Transplant. 2016 Mar;51(3):403-9. doi: 10.1038/bmt.2015.283. Epub 2015 Nov 23. Bone Marrow Transplant. 2016. PMID: 26595082 Clinical Trial.
Impact of low-dose TBI on outcomes of reduced intensity conditioning allogeneic hematopoietic stem cell transplantation for AML.
Aoki J, Seo S, Kanamori H, Tanaka M, Fukuda T, Onizuka M, Kobayashi N, Kondo T, Sawa M, Uchida N, Iwato K, Icihnohe T, Atsuta Y, Yano S, Takami A. Aoki J, et al. Among authors: kanamori h. Bone Marrow Transplant. 2016 Apr;51(4):604-6. doi: 10.1038/bmt.2015.297. Epub 2015 Dec 7. Bone Marrow Transplant. 2016. PMID: 26642343 No abstract available.
High-dose cytarabine added to CY/TBI improves the prognosis of cord blood transplantation for acute lymphoblastic leukemia in adults: a retrospective cohort study.
Arai Y, Kondo T, Shigematsu A, Tanaka J, Takahashi S, Kobayashi T, Uchida N, Onishi Y, Ishikawa J, Kanamori H, Sawa M, Yokota A, Kouzai Y, Takanashi M, Ichinohe T, Atsuta Y, Mizuta S. Arai Y, et al. Among authors: kanamori h. Bone Marrow Transplant. 2016 Dec;51(12):1636-1639. doi: 10.1038/bmt.2016.242. Epub 2016 Sep 19. Bone Marrow Transplant. 2016. PMID: 27643870 No abstract available.
Impact of graft-versus-host disease on outcomes after unrelated cord blood transplantation.
Kanda J, Morishima Y, Terakura S, Wake A, Uchida N, Takahashi S, Ono Y, Onishi Y, Kanamori H, Aotsuka N, Ozawa Y, Ogawa H, Sakura T, Ohashi K, Ichinohe T, Kato K, Atsuta Y, Teshima T, Murata M. Kanda J, et al. Among authors: kanamori h. Leukemia. 2017 Mar;31(3):663-668. doi: 10.1038/leu.2016.288. Epub 2016 Oct 17. Leukemia. 2017. PMID: 27748373
Reduced-intensity conditioning allogeneic hematopoietic cell transplantation for younger patients with acute myeloid leukemia: a registry-based study.
Yanada M, Kurosawa S, Kobayashi T, Ozawa Y, Kanamori H, Kobayashi N, Sawa M, Nakamae H, Uchida N, Hashimoto H, Fukuda T, Hirokawa M, Atsuta Y, Yano S. Yanada M, et al. Among authors: kanamori h. Bone Marrow Transplant. 2017 Jun;52(6):818-824. doi: 10.1038/bmt.2016.358. Epub 2017 Jan 23. Bone Marrow Transplant. 2017. PMID: 28112749 Clinical Trial.
852 results